What clinical trials of ablation for atrial fibrillation tell us - and what they do not.

Heart Rhythm O2
Ram Amuthan, Anne B Curtis

Abstract

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in clinical practice. Radiofrequency and cryoballoon catheter ablation are therapeutic options in addition to antiarrhythmic drug therapy for the treatment of AF. Ablation is effective at reducing recurrent atrial arrhythmias and also in the reduction of AF burden. Besides arrhythmia control, improvement in quality of life and clinical outcomes are also desirable goals with AF treatment. Randomized clinical trials have evaluated ablation in several patient populations, including symptomatic patients as first-line or second-line therapy, asymptomatic patients, and patients with heart failure. These trials clarify the durability of ablation in arrhythmia control, clarify quality-of-life improvement, and identify patient populations in whom ablation may be expected to improve clinical outcomes. In this review, we summarize the major clinical trials involving ablation; discuss the strengths, weakness, and clinical implications of these trials; and highlight the knowledge gaps in our current understanding of AF ablation for future clinical studies.

References

Sep 3, 1998·The New England Journal of Medicine·M HaïssaguerreJ Clémenty
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Jun 2, 2005·JAMA : the Journal of the American Medical Association·Oussama M WazniAndrea Natale
Mar 3, 2006·The New England Journal of Medicine·Hakan OralFred Morady
Oct 24, 2008·The New England Journal of Medicine·Mohammed N KhanUNKNOWN PABA-CHF Investigators
Nov 26, 2008·Circulation·Pierre JaïsMichel Haïssaguerre
Jan 28, 2010·JAMA : the Journal of the American Medical Association·David J WilberUNKNOWN ThermoCool AF Trial Investigators
May 22, 2010·Journal of the American College of Cardiology·Anita WokhluDouglas L Packer
Oct 26, 2012·The New England Journal of Medicine·Jens Cosedis NielsenPeter Steen Hansen
Mar 19, 2013·Journal of the American College of Cardiology·Douglas L PackerUNKNOWN STOP AF Cryoablation Investigators
Nov 19, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·John HummelUNKNOWN TTOP-AF Investigators
Nov 19, 2013·Circulation. Arrhythmia and Electrophysiology·Aakriti GuptaPrashanthan Sanders
Jan 3, 2014·Circulation. Arrhythmia and Electrophysiology·Ross J HunterRichard J Schilling
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Carlos A MorilloUNKNOWN RAAFT-2 Investigators
Aug 16, 2014·Journal of the American College of Cardiology·Andrea NataleFrancis E Marchlinski
Apr 15, 2015·Frontiers in Physiology·Olujimi A AjijolaKalyanam Shivkumar
May 7, 2015·The New England Journal of Medicine·Atul VermaUNKNOWN STAR AF II Investigators
Sep 19, 2015·Journal of the American College of Cardiology·Srinivas R DukkipatiUNKNOWN HeartLight Study Investigators
Dec 25, 2015·Journal of the American College of Cardiology·Julia VoglerDaniel Steven
Apr 5, 2016·The New England Journal of Medicine·Karl-Heinz KuckUNKNOWN FIRE AND ICE Investigators
Dec 23, 2016·Journal of the American College of Cardiology·Hiroshi SoharaKazutaka Aonuma
Sep 1, 2017·Journal of the American College of Cardiology·Sandeep PrabhuPeter M Kistler
Oct 11, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hugh CalkinsUNKNOWN Document Reviewers:
Dec 22, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jock A ClarnettePrashanthan Sanders
Feb 1, 2018·The New England Journal of Medicine·Nassir F MarroucheUNKNOWN CASTLE-AF Investigators
Mar 16, 2019·JAMA : the Journal of the American Medical Association·Daniel B MarkUNKNOWN CABANA Investigators
May 23, 2019·Circulation. Arrhythmia and Electrophysiology·Jeremiah WasserlaufRod Passman
Jun 27, 2020·Journal of the American College of Cardiology·Jeanne E PooleUNKNOWN CABANA Investigators and ECG Rhythm Core Lab
Sep 1, 2020·The New England Journal of Medicine·Paulus KirchhofUNKNOWN EAST-AFNET 4 Trial Investigators
Nov 17, 2020·The New England Journal of Medicine·Oussama M WazniUNKNOWN STOP AF First Trial Investigators
Nov 17, 2020·The New England Journal of Medicine·Jason G AndradeUNKNOWN EARLY-AF Investigators

❮ Previous
Next ❯

Software Mentioned

EAST
AFNET

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Journal of Atrial Fibrillation
Gulmira Kudaiberdieva, Bulent Gorenek
© 2021 Meta ULC. All rights reserved